Art Therapy for Enhancing Well-Being in Solitary Older Adults
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorNational Taiwan University Hospital
About this trial
This study explores the impact of art therapy on mental health and quality of life among solitary older adults. Participants will be randomly assigned to one of two groups: an experimental group receiving art therapy sessions or a control group with no intervention. The art therapy program includes 12 weekly sessions lasting 90 minutes each, focusing on creative expression, observation of art, and reflective discussions. These activities are designed to enhance emotional well-being, reduce depressive symptoms, and foster interpersonal connections.
Both groups will undergo evaluations before and after the 12-week study period. The assessments will include the Taiwanese version of the WHO Quality of Life-BREF (WHOQOL-BREF) and the Beck Depression Inventory (BDI) to measure changes in psychological health and life satisfaction. The findings aim to demonstrate the feasibility and benefits of art therapy as a non-pharmacological intervention for improving the well-being of solitary older adults.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age 65 years or older.
Living alone.
Mini-Mental State Examination (MMSE) score between 24 and 30, indicating no significant cognitive impairment.
Capable of providing informed consent.
Disqualifiers
Recent major life events (e.g., bereavement, severe illness) that could interfere with study participation.
History of brain injury or severe psychiatric conditions, such as schizophrenia or major depressive disorder requiring hospitalization.
Physical disabilities or motor impairments that prevent participation in art activities.
Participation in similar art therapy studies within the past 6 months.
Trial design
Design model
Parallel
Treatments tested in this trial
Art Therapy Program
BehavioralThe Art Therapy Program consists of 12 weekly group sessions, each lasting 90 minutes, designed to improve emotional well-being and quality of life in solitary older adults. Participants engage in structured activities that include creating art (e.g., drawing and painting), observing and interpreting art pieces, and reflective discussions to explore personal emotions and experiences. The sessions are led by trained facilitators under the supervision of licensed occupational therapists. This intervention follows a thematic progression: initial sessions focus on building trust and self-expression, mid-sessions deepen emotional awareness, and final sessions culminate in a creative project reflecting the participant's personal growth. Unlike other interventions, this program is tailored specifically for older adults living alone, addressing their unique challenges of isolation and reduced social interaction.
Treatment groups
22 Participants
are divided into 2 treatment groupsGroup A: Art Therapy Intervention GroupExperimental treatment 1 intervention
Group B: No Intervention Control GroupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Change in Quality of Life (WHOQOL-BREF)
The primary outcome is the change in quality of life scores, as measured by the Taiwanese version of the WHO Quality of Life Questionnaire-BREF (WHOQOL-BREF). This tool evaluates quality of life across four domains: physical health, psychological well-being, social relationships, and environmental factors. Each domain is scored independently, with scores ranging from 0 to 100. Higher scores indicate better quality of life, reflecting positive perceptions in that domain.
Time frame
Baseline (pre-intervention) and 12 weeks (post-intervention).Secondary outcomes
1
Change in Depressive Symptoms (BDI)
The Beck Depression Inventory (BDI) is a self-reported questionnaire used to measure the severity of depressive symptoms. It consists of 21 items, each scored on a scale of 0 to 3, with total scores ranging from 0 to 63. Higher scores indicate more severe depressive symptoms. The BDI is widely validated and commonly used in both clinical and research settings to assess changes in depression severity over time, making it ideal for evaluating the impact of interventions on mental health outcomes.
Time frame
Baseline (pre-intervention) and 12 weeks (post-intervention).Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
National Taiwan University Hospital
Lead sponsor
National Yunlin University of Science and Technology
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: